Evolution of brain gray matter loss in Huntington's disease: A meta-analysis

European Journal of Neurology

Volumn 20, Issue 2, 2013, Pages 315-321

  Lambrecq, V ^a,b,c   Langbour, N ^a   Guehl, D ^a,b,c   Bioulac, B ^a,b,c   Burbaud, P ^a,b,c   Rotge, J Y ^a,b,d  

^a INSTITUT DES MALADIES NEURODÉGÉNÉRATIVES   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

^d CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Basal ganglia; Huntington's disease; Meta analysis; Voxel based morphometry

Indexed keywords

ARTICLE; BASAL GANGLION; BRAIN; CORPUS STRIATUM; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; INSULA; META ANALYSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SYSTEMATIC REVIEW; VOXEL BASED MORPHOMETRY;

ADULT; ATROPHY; BRAIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HUNTINGTON DISEASE; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; NERVE DEGENERATION; NERVE FIBERS, UNMYELINATED;

EID: 84872375267     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03854.x     Document Type: Article

References (32)

1. Heinsen H, Strik M, Bauer M, et al. Cortical and striatal neuron number in Huntington's disease. Acta Neuropathol 1994; 91: 161-168.
2. Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 2000; 57: 1040-1044.
3. Ashburner J, Friston KJ. Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
4. Douaud G, Gaura V, Ribeiro MJ, et al. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562-1575.
5. Turkeltaub PE, Eden GF, Jones KM, Zeffiro TA. Meta-analysis of the functional neuroanatomy of single-word reading: method and validation. Neuroimage 2002; 16: 765-780.
6. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 2008; 64: 774-781.
7. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry 2008; 165: 1015-1023.
8. Rotge JY, Langbour N, Guehl D, et al. Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 2010; 35: 686-691.
9. Thieben MJ, Duggins AJ, Good CD, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815-1828.
10. Kipps CM, Duggins AJ, Mahant N, Gomes L, Ashburner J, McCusker EA. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005; 6: 650-655.
11. Kipps CM, Duggins AJ, McCusker EA, Calder AJ. Disgust and happiness recognition correlate with anteroventral insula and amygdala volume respectively in preclinical Huntington's disease. J Cogn Neurosci 2007; 19: 1206-1217.
12. Kassubek J, Juengling FD, Kioschies T, et al. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213-220.
13. Gavazzi C, Nave RD, Petralli R, et al. Combining functional and structural brain magnetic resonance imaging in Huntington disease. J Comput Assist Tomogr 2007; 31: 574-580.
14. Mühlau M, Weindl A, Wohlschläger AM, et al. Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm 2007; 114: 367-372.
15. Wolf RC, Vasic N, Schönfeldt-Lecuona C, et al. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. Brain 2007; 130: 2845-2857.
16. Beste C, Saft C, Konrad C, et al. Levels of error processing in Huntington's disease: a combined study using event-related potentials and voxel-based morphometry. Hum Brain Mapp 2008; 29: 121-130.
17. Gomez-Anson B, Alegret M, Munoz E, et al. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. Parkinsonism Relat Disord 2009; 15: 213-219.
18. Henley SMD, Wild EJ, Hobbs NZ, et al. Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol 2009; 256: 203-212.
19. Wolf RC, Vasic N, Schönfeldt-Lecuona C, Ecker D, Landwehrmeyer GB. Cortical dysfunction in patients with Huntington's disease during working memory performance. Hum Brain Mapp 2009; 30: 327-339.
20. Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology 2010; 74: 1208-1216.
21. Lancaster JL, Tordesillas-Gutierrez D, Martinez M, et al. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum Brain Mapp 2007; 28: 1194-1205.
22. Laird AR, Lancaster JL, Fox PT. BrainMap: the social evolution of a functional neuroimaging database. Neuroinformatics 2005; 3: 65-78.
23. Laird AR, Fox PM, Price CJ, et al. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum Brain Mapp 2005; 25: 155-164.
24. Kochunov P, Lancaster J, Thompson P, et al. An optimized individual target brain in the Talairach coordinate system. Neuroimage 2002; 17: 922-927.
25. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559-577.
26. Harris GJ, Pearlson GD, Peyser CE, et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992; 31: 69-75.
27. Aylward EH, Codori AM, Barta PE, Pearlson GD, Harris GJ, Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996; 53: 1293-1296.
28. Rosas HD, Koroshetz WJ, Chen YI, et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003; 60: 1615-1620.
29. Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington's disease. J Psychiatry Neurosci 2006; 31: 21-29.
30. Gutekunst CA, Li SH, Yi H, et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 1999; 19: 2522-2534.
31. Mühlau M, Gaser C, Wohlschläger AM, et al. Striatal gray matter loss in Huntington's disease is leftward biased. Mov Disord 2007; 22: 1169-1173.
32. Beste C, Konrad C, Saft C, et al. Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system - evidence from event-related potentials. Exp Neurol 2009; 216: 148-157.